whatisglowblend.com

Glow blend · Updated

What is the Glow blend?

Short answer

The Glow blend is an injectable mix of three peptides, GHK-Cu, BPC-157 and TB-500, marketed to rejuvenate skin and speed healing.[1][2] It is not FDA-approved, and no published study has tested the three together in people.[3][5][22][23] Two of its ingredients, BPC-157 and TB-500, are banned in sport.[20]

Start your assessment

Your card is only held at checkout. You’re charged only if a provider prescribes.

  • Licensed provider review
  • Online, no office visit
  • Every fact cited to its source

Quick fit check

Tick anything that applies to you. Nothing you tick is saved or sent anywhere.

  • Under the WADA Prohibited List, BPC-157 and TB-500 are banned in and out of competition, and USADA says an exemption for BPC-157 is unlikely to be granted.[20][22] A provider will weigh this against your sport's rules.

  • In one physician's opinion, people with active cancer, a recent cancer history or elevated risk should skip these peptides, because repair signals also affect cell growth.[4] A provider will weigh your history, since no study has tested this blend.[5]

  • Copper peptide creams and serums have been sold for decades, while the Glow blend is injected.[1][3] A provider can weigh whether a topical product fits your goal.

  • No published study has tested GHK-Cu, BPC-157 and TB-500 together, and FDA found no human data for TB-500.[5][12] A provider will weigh this gap in the evidence.

  • Doctors strongly advise against at-home injections, and one dermatologist links unregulated online sources to contamination and incorrect dosing.[1] A provider will weigh how any product is sourced and given.

How to get started

  1. Answer health questions

    An online assessment about your health, history and goals.

  2. A licensed provider reviews it

    They decide whether a prescription is safe and appropriate for you.

  3. If prescribed, it ships to you

    Your card is only held at checkout. You’re charged only if a provider prescribes.

Not ready yet?

Get occasional updates on the Glow blend: new research, safety news and rule changes.

Used only to send these updates. Unsubscribe anytime.

Key facts

What's in it
GHK-Cu, BPC-157 and TB-500, combined in one injectable product.[1][2]
What it's marketed for
Skin rejuvenation, collagen, healing and less inflammation, including recovery after cosmetic procedures. These are claims, not proven benefits.[1][3][5]
FDA status
Not FDA-approved. None of the three ingredients is an approved drug.[3][22][23]
Evidence on the combination
None. As of October 2026, no published study had tested GHK-Cu, BPC-157 and TB-500 together, in people or in animals.[5][6]
In sport
Contains two substances banned at all times by the World Anti-Doping Agency: BPC-157 and TB-500.[20]
How it's taken
By injection under the skin, after the peptide is reconstituted (mixed with liquid).[1][3]

Ingredient by ingredient

IngredientWhat it is and its status
GHK-CuA copper-bound form of a small peptide made naturally in the body, long used in skin creams.[3][7] Not an approved drug, and FDA has said it intends to ask its compounding advisers about it before the end of February 2027.[3][14]
BPC-157A synthetic 15 amino acid peptide based on a compound first found in human stomach juice.[11][22] Not approved by FDA or any other health authority, and banned in sport.[20][22]
TB-500A synthetic 7 amino acid fragment of the protein thymosin beta-4.[12][13] Not FDA-approved, FDA found no human data on it, and it is banned in sport.[12][20][23]

What's in it

GHK-Cu
GHK is a tiny peptide of three amino acids that the body makes on its own, and GHK-Cu is its copper-bound form.[7] Copper peptide serums and creams have been sold for skin care for decades.[3]
BPC-157
A lab-made peptide that copies part of a “body protection compound” first isolated from human stomach juice.[22] FDA describes it as a peptide of 15 amino acids.[11]
TB-500
A lab-made peptide of 7 amino acids that FDA lists as a fragment of thymosin beta-4.[12][13]
Related blends
BPC-157 plus TB-500 on its own is known as the “wolverine” stack, and adding GHK-Cu, sometimes with a fourth peptide called KPV, gives versions called “glow” or “KLOW.”[1][2]

Why it's combined (the claim)

The pitch
Supporters describe Glow as a blend whose peptides work together to rejuvenate skin, speed healing, reduce inflammation and stimulate collagen.[1] It is also promoted for recovery after cosmetic procedures such as lasers, microneedling and peels.[1]
GHK-Cu for skin
People claim GHK-Cu speeds wound healing, reduces scarring and helps rebuild collagen.[2]
BPC-157 and TB-500 for healing
Both are promoted for healing and injury recovery, though TB-500 has even less research behind it than BPC-157.[1][2]
“Better together”
Peptide “glow stacks” are sold on the idea that the parts work better together than alone.[4] That idea has not been tested for this blend.[5][6]

What the evidence shows

The combination itself
A PubMed search on October 17, 2026 found 6 papers that mention all three peptides, and all 6 were reviews of earlier research, not tests of the combination.[5] A 2026 review of peptides for healthy aging listed “combination therapy effects” among the significant gaps in knowledge.[6]
Closest human data
Nearest in people: a 2021 look back at medical charts, where 3 of 4 patients given BPC-157 plus thymosin beta-4 in the knee said they felt better.[10] It had no control group and did not include GHK-Cu.[9][10]
GHK-Cu
A 2026 systematic review found decades of lab and animal research on GHK-Cu, but its human evidence is thin, mostly small trials of face creams.[7] No published human studies show that injecting it is safe and effective.[3] A 2026 review for sports medicine doctors found no clinical data supporting GHK-Cu for muscle, tendon or joint conditions.[8]
BPC-157
A 2026 systematic review found only 3 human studies with 30 people in total, all of poor quality, and rated the certainty of the evidence as very low.[9]
TB-500
For TB-500, FDA reviewers could not find any human study or human exposure data, whatever the route.[12]

Legal and regulatory status

Not approved
GHK-Cu is not an approved drug, BPC-157 is not approved by FDA or any other global health authority, and the BPC-157 and TB-500 stack is not FDA-approved.[3][22][23]
Compounding rules
A compounding pharmacy working under section 503A can use a bulk ingredient only if it is part of an FDA-approved drug, has a USP or NF monograph, or is on FDA’s 503A bulks list.[16]
BPC-157 and TB-500
In July 2026, FDA’s compounding advisers voted 8 to 6, with 1 abstention, to recommend adding both to the 503A bulks list, against the advice of FDA staff.[17][18] The vote is non-binding, and FDA must publish proposed rules before anything becomes official.[17]
GHK-Cu
Injectable GHK-Cu was in FDA’s “category 2” of substances with potential safety risks until the nomination was withdrawn.[13] FDA lists GHK-Cu among substances being considered for the 503A bulks list and has said it intends to consult its advisers before the end of February 2027.[14][15]
Pending interim policy
On October 14, 2026, White House reviewers received an FDA interim policy on compounding certain peptides, and its text and covered peptides have not been made public.[19]

Risks and unknowns

No safety data on the mix
There is very little information on most of these peptides on their own, let alone on what happens when they are combined.[2] No study has measured how the three interact or what a safe combined dose would be.[5][6]
Immune reactions
FDA has flagged a possible risk of immune reactions, linked to peptide clumping or impurities, for compounded BPC-157, TB-500 and injectable GHK-Cu.[13]
Unknown harm in humans
For all three, the human safety picture is thin: FDA says it cannot tell whether BPC-157 or TB-500 would harm people, and it notes limited human data on injected GHK-Cu.[13]
Product quality
Many injectable versions come from a grey market of online sellers.[3] One dermatologist warns that unregulated sources are where contamination, incorrect dosing and poor manufacturing show up.[1]
Injecting at home
Doctors strongly advise against at-home injections, and dermatologists told reporters they are advising patients to hold off from injecting anything.[1][3]
Cancer history
One physician advises people with active cancer, a recent cancer history or a high cancer risk to skip these peptides, because the same signals that help repair also affect cell growth.[4]

Common questions

What's in the Glow blend?

Three peptides: GHK-Cu, a copper-bound peptide the body makes naturally; BPC-157, a synthetic 15 amino acid peptide; and TB-500, a synthetic 7 amino acid fragment of thymosin beta-4.[7][11][12][13] A related version called KLOW adds a fourth peptide, KPV.[2]

Why are GHK-Cu, BPC-157 and TB-500 combined?

The claim is that GHK-Cu helps skin and collagen while BPC-157 and TB-500 help healing, and that together they work better than alone.[1][2][4] No study has tested whether combining them adds any benefit.[5][6]

Is the Glow blend FDA-approved?

No. None of the three ingredients is an FDA-approved drug.[3][22][23] FDA advisers recommended in July 2026 that pharmacies be allowed to compound BPC-157 and TB-500, but the vote is non-binding, and GHK-Cu is still awaiting its own advisory review.[14][15][17] A separate FDA interim policy covering some peptides was still waiting on White House review as of October 16, 2026.[19]

Has the Glow blend been tested in people?

No. As of October 2026, no published study had tested GHK-Cu, BPC-157 and TB-500 together.[5] The closest is a 2021 chart review of 4 people who got knee injections of BPC-157 with thymosin beta-4, without GHK-Cu.[10] FDA found no human data at all for TB-500.[12]

How is the Glow blend different from the wolverine stack?

The wolverine stack is BPC-157 plus TB-500, used mainly for injury recovery.[2][23] The Glow blend adds GHK-Cu and is marketed for skin as well as healing.[1][2] Both share the same regulatory and sport issues for BPC-157 and TB-500.[17][20]

Is the Glow blend banned in sports?

Yes, because it contains two prohibited substances.[20] The 2026 WADA Prohibited List bans BPC-157 under S0 and thymosin beta-4 derivatives such as TB-500 under S2, at all times.[20] Both stay prohibited on the 2027 list.[21] GHK-Cu is not named on the list, but S0 covers any substance not listed elsewhere that has no government approval for human therapeutic use.[20] Tested athletes should check with their anti-doping agency before using any peptide product.

See if a provider recommends the Glow blend

Complete an online health assessment. A licensed provider reviews it and decides whether the Glow blend or another option is appropriate for you.

Start your assessment

Your card is only held at checkout. You’re charged only if a provider prescribes. Not everyone qualifies. A provider decides based on your health history.

Sources

  1. What to Know About the Trending Glow Peptide Blend (Jessica Fields). NewBeauty. January 6, 2026.
  2. The science behind the peptide craze (Bethany Brookshire). Scientific American. April 18, 2026.
  3. The copper peptide trend has gone from creams to injections, ahead of the science (Will Stone). NPR. September 7, 2026.
  4. Everything to Know about Trendy Peptide Injections and Glow Stacks (Tatiana Bido). NewBeauty. April 14, 2026.
  5. PubMed search: GHK-Cu AND BPC-157 AND TB-500 (6 results, all reviews). National Library of Medicine. Searched October 17, 2026.
  6. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging (Mavrych V, Shypilova I, Bolgova O). Frontiers in Aging, via PubMed. April 7, 2026.
  7. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu in Topical Microneedle Delivery (Najafi N, et al.). Archives of Internal Medicine Research, via PubMed. July 2026.
  8. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians (Mayfield CK, et al.). American Journal of Sports Medicine, via PubMed. January 2026.
  9. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety (Poolton JT, Minett J, Kazmi A). Acta Orthopaedica Belgica, via PubMed. October 8, 2026.
  10. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain (Lee E, Padgett B). Alternative Therapies in Health and Medicine, via PubMed. July 2021.
  11. FDA Briefing Document: BPC-157-Related Bulk Drug Substances, Pharmacy Compounding Advisory Committee. U.S. Food and Drug Administration. July 2026.
  12. FDA Briefing Document: TB-500-Related Bulk Drug Substances, Pharmacy Compounding Advisory Committee. U.S. Food and Drug Administration. July 2026.
  13. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. Content current as of April 22, 2026.
  14. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act. U.S. Food and Drug Administration. Updated May 14, 2026.
  15. Meeting of the Pharmacy Compounding Advisory Committee (before the end of February 2027). U.S. Food and Drug Administration. Content current as of April 15, 2026.
  16. Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act. U.S. Food and Drug Administration. Content current as of May 14, 2026.
  17. FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?. ABC News. July 24, 2026.
  18. FDA Panel Backs 6 Peptides for Compounding. The American Journal of Managed Care (AJMC). Accessed October 17, 2026.
  19. FDA Submits Interim Peptide Compounding Policy for White House Review: What Pharmacies Should Know. Buchanan Ingersoll & Rooney PC. October 16, 2026.
  20. World Anti-Doping Code International Standard: Prohibited List 2026. World Anti-Doping Agency. In effect January 1, 2026.
  21. Athlete Advisory: What's New on the 2027 WADA Prohibited List?. U.S. Anti-Doping Agency (USADA). October 6, 2026.
  22. BPC-157: What Athletes Should Know About the Prohibited Experimental Peptide. U.S. Anti-Doping Agency (USADA). Updated August 10, 2026.
  23. What's in the Wolverine Peptide Stack? Research and Safety. Healthline (medically reviewed by Ami Patel, PharmD, BCPS). Updated October 14, 2026.